Ongoing Disclosure Notice – Various

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
15-Sep-22
Date of last disclosure:
31-Mar-22
Director or senior manager giving disclosure
Full name(s):
Edward John Harvey
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Heartland Bank Limited
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Beneficial Owner
For that relevant interest-
Number held in class before acquisition or disposal:
147,787
Number held in class after acquisition or disposal:
157,971
Current registered holder(s):
Susan Shirley Harvey
Registered holder(s) once transfers are registered:
Susan Shirley Harvey
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not Applicable
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not Applicable
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:9 September 2022
Nature of transaction:
Acqusition of shares under
Heartland's non-underwritten NZ$70
million share purchase plan
announced on 23 August 2022.
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or recieved for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$17,999.20
Number of financial products to which the transaction related: 10,184
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were aquired or disposed of during a closed period:Not applicable
Whether prior written clearance was provided to allow the aquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Cerification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclsoure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
15 September 2022
Name and title of authorised person:
Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
15 September 2022
Date of last disclosure:
5 September 2022
Director or senior manager giving disclosure
Full name(s):
Bruce Robertson Irvine
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Heartland Bank Limited
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares in Heartland
Group Holdings Limited (NZX/ASX:
HGH)
Nature of the affected relevant interest(s):
(a) Registered Holder and
Beneficial Owner
(b) Beneficial Owner
For that relevant interest-
Number held in class before acquisition or disposal:
(a)138,283 (b) 504,539
Number held in class after acquisition or disposal:
(a)166,573 (b) 532,829
Current registered holder(s):
(a) Bruce Robertson Irvine
(b) Mary Therese Irvine
Registered holder(s) once transfers are registered:
(a) Bruce Robertson Irvine
(b) Mary Therese Irvine
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:9 September 2022
Nature of transaction:
Acqusition of shares under
Heartland's non-underwritten
NZ$70 million share purchase plan
announced on 23 August 2022.
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
(a)$49,999.75 (b)$49,999.75
Number of financial products to which the transaction related: (a)28,290 (b)28,290
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Not applicable
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
15 September 2022
Name and title of authorised person:
Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
15-Sep-22
Date of last disclosure:
26-Mar-21
Director or senior manager giving disclosure
Full name(s):
Andrew Peter Dixson
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Not Applicable
Position held in listed issuer:
Chief Financial Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Registered Holder and Beneficial
Owner
For that relevant interest-
Number held in class before acquisition or disposal:
237,895
Number held in class after acquisition or disposal:
252,040
Current registered holder(s):
Andrew Peter Dixson
Registered holder(s) once transfers are registered:
Andrew Peter Dixson
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not Applicable
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not Applicable
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:9 September 2022
Nature of transaction:
Acqusition of shares under
Heartland's non-underwritten NZ$70
million share purchase plan
announced on 23 August 2022.
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or recieved for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$24,999.87
Number of financial products to which the transaction related: 14,145
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were aquired or disposed of during a closed period:Not applicable
Whether prior written clearance was provided to allow the aquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Cerification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclsoure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:

Date of signature:
15 September 2022
Name and title of authorised person:
Phoebe Gibbons, General Counsel